Imaging Features of Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Surviving Beyond 1 Year After Combined Therapy
Wei-Ming Lin, Hui-Ling Huang, Sheng-Nan Lu, Tse-Yen Yang, Hao-Chung Wang, Sheng-Lung Hsu, Chia-Hsuan Lai, Te-Sheng Chang · 2025
Read Imaging Features of Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Surviving Beyond 1 Year After Combined Therapy by Wei-Ming Lin, Hui-Ling Huang, Sheng-Nan Lu, Tse-Yen Yang, Hao-Chung Wang, Sheng-Lung Hsu, Chia-Hsuan Lai, Te-Sheng Chang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785578.txt.
Description
Wei-Ming Lin and colleagues published a cancer study in 2025 on liver tumors that invade the portal vein. That invasion is a severe complication with poor outlook. Some patients, though, live well past a year on combined treatment. The authors described what those longer survivors looked like on scans and records.
The study covered twenty-six such patients at one center. Most had extensive vein invasion at the start. Liver function was usually well preserved despite the spread. Scans were checked at the start and again at six months. Most patients showed a measurable tumor response to therapy. The report aims to help doctors recognize which treated patients may do better.
Catalog record
| CREATOR | Wei-Ming Lin, Hui-Ling Huang, Sheng-Nan Lu, Tse-Yen Yang, Hao-Chung Wang, Sheng-Lung Hsu, Chia-Hsuan Lai, Te-Sheng Chang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |